[
{
"old_id":"1",
"old_nametree":"Authors and legal information",
"old_numtree":"1.0.0.0",
"old_htmlpage":"ENAS5408_1.0.0.0",
"new_id":"1",
"new_nametree":"Authors and legal information",
"new_numtree":"1.0.0.0",
"new_htmlpage":"ENAS5408_1.0.0.0"
},
{
"old_id":"2",
"old_nametree":"Diagnosis and pathology",
"old_numtree":"2.0.0.0",
"old_htmlpage":"ENAS5408_2.0.0.0",
"new_id":"2",
"new_nametree":"Diagnosis and pathology",
"new_numtree":"2.0.0.0",
"new_htmlpage":"ENAS5408_2.0.0.0"
},
{
"old_id":"3",
"old_nametree":"Staging and risk assessment",
"old_numtree":"3.0.0.0",
"old_htmlpage":"null",
"new_id":"3",
"new_nametree":"Staging and risk assessment",
"new_numtree":"3.0.0.0",
"new_htmlpage":"null"
},
{
"old_id":"4",
"old_nametree":"Overview",
"old_numtree":"3.1.0.0",
"old_htmlpage":"ENAS5408_3.1.0.0",
"new_id":"4",
"new_nametree":"Overview",
"new_numtree":"3.1.0.0",
"new_htmlpage":"ENAS5408_3.1.0.0"
},
{
"old_id":"5",
"old_nametree":"Lugano classification",
"old_numtree":"3.2.0.0",
"old_htmlpage":"ENAS5408_3.2.0.0",
"new_id":"5",
"new_nametree":"Lugano classification",
"new_numtree":"3.2.0.0",
"new_htmlpage":"ENAS5408_3.2.0.0"
},
{
"old_id":"6",
"old_nametree":"Diagnostic work-up",
"old_numtree":"3.3.0.0",
"old_htmlpage":"ENAS5408_3.3.0.0",
"new_id":"6",
"new_nametree":"Diagnostic work-up",
"new_numtree":"3.3.0.0",
"new_htmlpage":"ENAS5408_3.3.0.0"
},
{
"old_id":"7",
"old_nametree":"MIPI and MIPI-C risk stratification",
"old_numtree":"3.4.0.0",
"old_htmlpage":"ENAS5408_3.4.0.0",
"new_id":"7",
"new_nametree":"MIPI and MIPI-C risk stratification",
"new_numtree":"3.4.0.0",
"new_htmlpage":"ENAS5408_3.4.0.0"
},
{
"old_id":"8",
"old_nametree":"Leukaemic non-nodal subtype of MCL",
"old_numtree":"3.5.0.0",
"old_htmlpage":"ENAS5408_3.5.0.0",
"new_id":"8",
"new_nametree":"Leukaemic non-nodal subtype of MCL",
"new_numtree":"3.5.0.0",
"new_htmlpage":"ENAS5408_3.5.0.0"
},
{
"old_id":"9",
"old_nametree":"Molecular Pathogenesis of MCL",
"old_numtree":"3.6.0.0",
"old_htmlpage":"ENAS5408_3.6.0.0",
"new_id":"9",
"new_nametree":"Molecular Pathogenesis of MCL",
"new_numtree":"3.6.0.0",
"new_htmlpage":"ENAS5408_3.6.0.0"
},
{
"old_id":"10",
"old_nametree":"Treatment",
"old_numtree":"4.0.0.0",
"old_htmlpage":"null",
"new_id":"10",
"new_nametree":"Treatment",
"new_numtree":"4.0.0.0",
"new_htmlpage":"null"
},
{
"old_id":"11",
"old_nametree":"First-line: Stages I–II",
"old_numtree":"4.1.0.0",
"old_htmlpage":"ENAS5408_4.1.0.0",
"new_id":"11",
"new_nametree":"First-line: Stages I–II",
"new_numtree":"4.1.0.0",
"new_htmlpage":"ENAS5408_4.1.0.0"
},
{
"old_id":"12",
"old_nametree":"First-line: Stages III–IV",
"old_numtree":"4.2.0.0",
"old_htmlpage":"ENAS5408_4.2.0.0",
"new_id":"12",
"new_nametree":"First-line: Stages III–IV",
"new_numtree":"4.2.0.0",
"new_htmlpage":"ENAS5408_4.2.0.0"
},
{
"old_id":"13",
"old_nametree":"Therapeutic recommendations",
"old_numtree":"4.3.0.0",
"old_htmlpage":"ENAS5408_4.3.0.0",
"new_id":"13",
"new_nametree":"Therapeutic recommendations",
"new_numtree":"4.3.0.0",
"new_htmlpage":"ENAS5408_4.3.0.0"
},
{
"old_id":"14",
"old_nametree":"Elderly patients",
"old_numtree":"4.4.0.0",
"old_htmlpage":"ENAS5408_4.4.0.0",
"new_id":"14",
"new_nametree":"Elderly patients",
"new_numtree":"4.4.0.0",
"new_htmlpage":"ENAS5408_4.4.0.0"
},
{
"old_id":"15",
"old_nametree":"Younger patients",
"old_numtree":"4.5.0.0",
"old_htmlpage":"ENAS5408_4.5.0.0",
"new_id":"15",
"new_nametree":"Younger patients",
"new_numtree":"4.5.0.0",
"new_htmlpage":"ENAS5408_4.5.0.0"
},
{
"old_id":"16",
"old_nametree":"Relapsed disease",
"old_numtree":"4.6.0.0",
"old_htmlpage":"ENAS5408_4.6.0.0",
"new_id":"16",
"new_nametree":"Relapsed disease",
"new_numtree":"4.6.0.0",
"new_htmlpage":"ENAS5408_4.6.0.0"
},
{
"old_id":"17",
"old_nametree":"Response evaluation",
"old_numtree":"4.7.0.0",
"old_htmlpage":"ENAS5408_4.7.0.0",
"new_id":"17",
"new_nametree":"Response evaluation",
"new_numtree":"4.7.0.0",
"new_htmlpage":"ENAS5408_4.7.0.0"
},
{
"old_id":"18",
"old_nametree":"Personalised medicine",
"old_numtree":"5.0.0.0",
"old_htmlpage":"ENAS5408_5.0.0.0",
"new_id":"18",
"new_nametree":"Personalised medicine",
"new_numtree":"5.0.0.0",
"new_htmlpage":"ENAS5408_5.0.0.0"
},
{
"old_id":"19",
"old_nametree":"Follow-up, long-term implications",
"old_numtree":"6.0.0.0",
"old_htmlpage":"ENAS5408_6.0.0.0",
"new_id":"19",
"new_nametree":"Follow-up, long-term implications",
"new_numtree":"6.0.0.0",
"new_htmlpage":"ENAS5408_6.0.0.0"
},
{
"old_id":"20",
"old_nametree":"Summary of recommendations",
"old_numtree":"7.0.0.0",
"old_htmlpage":"null",
"new_id":"20",
"new_nametree":"Summary of recommendations",
"new_numtree":"7.0.0.0",
"new_htmlpage":"null"
},
{
"old_id":"21",
"old_nametree":"Diagnosis and pathology",
"old_numtree":"7.1.0.0",
"old_htmlpage":"ENAS5408_7.1.0.0",
"new_id":"21",
"new_nametree":"Diagnosis and pathology",
"new_numtree":"7.1.0.0",
"new_htmlpage":"ENAS5408_7.1.0.0"
},
{
"old_id":"22",
"old_nametree":"Staging and risk assessment",
"old_numtree":"7.2.0.0",
"old_htmlpage":"null",
"new_id":"22",
"new_nametree":"Staging and risk assessment",
"new_numtree":"7.2.0.0",
"new_htmlpage":"null"
},
{
"old_id":"23",
"old_nametree":"Overview",
"old_numtree":"7.2.1.0",
"old_htmlpage":"ENAS5408_7.2.1.0",
"new_id":"23",
"new_nametree":"Overview",
"new_numtree":"7.2.1.0",
"new_htmlpage":"ENAS5408_7.2.1.0"
},
{
"old_id":"24",
"old_nametree":"Leukaemic non-nodal subtype of MCL",
"old_numtree":"7.2.2.0",
"old_htmlpage":"ENAS5408_7.2.2.0",
"new_id":"24",
"new_nametree":"Leukaemic non-nodal subtype of MCL",
"new_numtree":"7.2.2.0",
"new_htmlpage":"ENAS5408_7.2.2.0"
},
{
"old_id":"25",
"old_nametree":"Treatment",
"old_numtree":"7.3.0.0",
"old_htmlpage":"null",
"new_id":"25",
"new_nametree":"Treatment",
"new_numtree":"7.3.0.0",
"new_htmlpage":"null"
},
{
"old_id":"26",
"old_nametree":"First-line: Stages I–II",
"old_numtree":"7.3.1.0",
"old_htmlpage":"ENAS5408_7.3.1.0",
"new_id":"26",
"new_nametree":"First-line: Stages I–II",
"new_numtree":"7.3.1.0",
"new_htmlpage":"ENAS5408_7.3.1.0"
},
{
"old_id":"27",
"old_nametree":"First-line: Stages III–IV",
"old_numtree":"7.3.2.0",
"old_htmlpage":"ENAS5408_7.3.2.0",
"new_id":"27",
"new_nametree":"First-line: Stages III–IV",
"new_numtree":"7.3.2.0",
"new_htmlpage":"ENAS5408_7.3.2.0"
},
{
"old_id":"28",
"old_nametree":"Elderly patients",
"old_numtree":"7.3.3.0",
"old_htmlpage":"ENAS5408_7.3.3.0",
"new_id":"28",
"new_nametree":"Elderly patients",
"new_numtree":"7.3.3.0",
"new_htmlpage":"ENAS5408_7.3.3.0"
},
{
"old_id":"29",
"old_nametree":"Younger patients",
"old_numtree":"7.3.4.0",
"old_htmlpage":"ENAS5408_7.3.4.0",
"new_id":"29",
"new_nametree":"Younger patients",
"new_numtree":"7.3.4.0",
"new_htmlpage":"ENAS5408_7.3.4.0"
},
{
"old_id":"30",
"old_nametree":"Relapsed disease",
"old_numtree":"7.3.5.0",
"old_htmlpage":"ENAS5408_7.3.5.0",
"new_id":"30",
"new_nametree":"Relapsed disease",
"new_numtree":"7.3.5.0",
"new_htmlpage":"ENAS5408_7.3.5.0"
},
{
"old_id":"31",
"old_nametree":"Response evaluation",
"old_numtree":"7.3.6.0",
"old_htmlpage":"ENAS5408_7.3.6.0",
"new_id":"31",
"new_nametree":"Response evaluation",
"new_numtree":"7.3.6.0",
"new_htmlpage":"ENAS5408_7.3.6.0"
},
{
"old_id":"32",
"old_nametree":"Personalised medicine",
"old_numtree":"7.4.0.0",
"old_htmlpage":"ENAS5408_7.4.0.0",
"new_id":"32",
"new_nametree":"Personalised medicine",
"new_numtree":"7.4.0.0",
"new_htmlpage":"ENAS5408_7.4.0.0"
},
{
"old_id":"33",
"old_nametree":"Follow-up, long-term implications",
"old_numtree":"7.5.0.0",
"old_htmlpage":"ENAS5408_7.5.0.0",
"new_id":"33",
"new_nametree":"Follow-up, long-term implications",
"new_numtree":"7.5.0.0",
"new_htmlpage":"ENAS5408_7.5.0.0"
},
{
"old_id":"34",
"old_nametree":"Glossary",
"old_numtree":"8.0.0.0",
"old_htmlpage":"ENAS5408_8.0.0.0",
"new_id":"34",
"new_nametree":"Glossary",
"new_numtree":"8.0.0.0",
"new_htmlpage":"ENAS5408_8.0.0.0"
}
]